Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (191-200 of 320) with videos related to

Pageof 32
Sort By:
Endoscopy International Open|June 25, 2026
Pan-enteric Capsule Endoscopy in Crohn's Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based StudyCarlo Calabrese, Nikolas Dussias, Fernando Rizzello, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2020
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapyLucrezia Laterza, Maria Elena Ainora, Matteo Garcovich, et al.
United European Gastroenterology Journal|November 9, 2019
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel diseaseLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.
Helicobacter|November 12, 2021
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMADRocco Maurizio Zagari, Marco Romano, Leonardo Frazzoni, et al.
Human Molecular Genetics|March 7, 2003
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHCTariq Ahmad, Matt Neville, Sara E Marshall, et al.
Inflammatory Bowel Diseases|August 5, 2004
Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1Jin Hong Low, Fiona A Williams, Xuesong Yang, et al.
Plos One|October 27, 2017
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with InfliximabFranco Scaldaferri, Daria D'Ambrosio, Grainne Holleran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2021
Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 TrialsEvelien M J Beelen, Daan Nieboer, Jeanine H C Arkenbosch, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-AnalysisBruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2025
Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysisMohammad Al Hayek, Mohammed S Beshr, Mohamedhen Vall Nounou, et al.
Pageof 32

Showing results (191-200 of 320) with videos related to

Sort By:
Pageof 32
Endoscopy International Open|June 25, 2026
Pan-enteric Capsule Endoscopy in Crohn's Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based StudyCarlo Calabrese, Nikolas Dussias, Fernando Rizzello, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2020
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapyLucrezia Laterza, Maria Elena Ainora, Matteo Garcovich, et al.
United European Gastroenterology Journal|November 9, 2019
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel diseaseLuisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, et al.
Helicobacter|November 12, 2021
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMADRocco Maurizio Zagari, Marco Romano, Leonardo Frazzoni, et al.
Human Molecular Genetics|March 7, 2003
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHCTariq Ahmad, Matt Neville, Sara E Marshall, et al.
Inflammatory Bowel Diseases|August 5, 2004
Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1Jin Hong Low, Fiona A Williams, Xuesong Yang, et al.
Plos One|October 27, 2017
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with InfliximabFranco Scaldaferri, Daria D'Ambrosio, Grainne Holleran, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 23, 2021
Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 TrialsEvelien M J Beelen, Daan Nieboer, Jeanine H C Arkenbosch, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-AnalysisBruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2025
Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysisMohammad Al Hayek, Mohammed S Beshr, Mohamedhen Vall Nounou, et al.
Pageof 32